Mira Pharmaceuticals Inc (MIRA) Annual Balance Sheets

Annual · GAAP · USD millions
Access MIRA quarterly Balance Sheets →
Examining balance sheet movements between Mira Pharmaceuticals Inc and reveals how Dec 31 2025 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent6.35
Short-term Investments, Total4.68
Cash & Short-term Investments10.00
Other Receivables0.04
Prepaid Expense, Current AS0.03
Total Current Assets11.09
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets11.09
Liabilities
Accounts Payable, Current AC0.13
Accrued Liabilities, Current AC0.00
Other Liabilities, Current0.57
Total Current Liabilities0.70
Total Long-term Debt0.00
Accrued Compensation Related Party-
Total Liabilities0.70
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock49.97
Retained Earnings / Accumulated Deficit-39.58
Other Equity0.00
Common Stockholder's Equity10.39
Total Stockholder's Equity10.39
Liabilities & Stockholder's Equity11.09
4 historic quarters locked

Sign in to unlock the full Mira Pharmaceuticals Inc balance sheet history.

About Mira Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-014001

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License